[1]
J. Vinhas, P. Assis, C. Oliveira, F. Crespo, and M. M. Prata, “Hemostatic changes associated with recombinant human erythropoietin (rHu Epo) treatment”., Acta Med Port, vol. 4, no. 1, pp. 9–12, Feb. 1991.